Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Lemborexant on CPAP Compliance in OSA Patients with Low Respiratory Arousal Threshold
TCTR20260626003Phase 2Not yet recruiting
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lemborexant in obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by Faculty of Medicine, Chulalongkorn University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
lemborexant
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on TCTR20260626003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260626003.